Login
Companies $PYXS
$1.43 +$0.02 (1.34%) After hours
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc.

pyxisoncology.com

What Do They Do?

Develops an investigational cancer treatment for patients with solid tumors, focusing on recurrent and metastatic head and neck cancer.

How Do They Make Money?

Pyxis sells royalty rights and may receive milestone payments based on partners’ performance, plus royalties tied to product sales under collaboration and licensing arrangements.

revenue
SegmentShareRevenue
Royalty Revenues
Licensed
0.0%
Sale of Royalty Rights
80%
Milestone Revenue
Sold outright

20%

Who Are Their Customers?

Pyxis works with counterparties to collaboration and licensing arrangements; Merck is a partner in a clinical-trial collaboration. These partners may pay milestone fees and royalties on sales.

Do Revenues Turn Into Profits?

No. It lost $79.6M in FY2025.

Operating income, FY2025
−609% of revenue
▲ +6% (Loss) vs FY2024 (−$89.5M, −554%)
Net income, FY2025
−575% of revenue
▼ −3% (Loss) vs FY2024 (−$77.3M, −479%)
Free cash flow, FY2025
−458% of revenue
▼ −10% (Loss) vs FY2024 (−$57.9M, −359%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▲ +9% (Loss)
vs −$22M in Q3 FY2025
  • Sep 3, 2026 Thomas Civik appointed permanent CEO and chairman John Flavin became lead independent director and remains on the board.

A narrower development focus The older report described a broad portfolio spanning antibody-drug conjugates, immunotherapy candidates and preclinical antibody discovery. The latest report centers development on MICVO, with a focus on head and neck cancer and combination studies.

Revenue over time
Royalty Revenues Sale of Royalty Rights Milestone Revenue
$20M$10M$0

Who Do They Compete With?

Competes with AbbVie, Abcure, ADC Therapeutics, Alligator Bioscience, Astellas Pharma, AstraZeneca, Celldex Therapeutics, Daiichi Sankyo, Eucure Biopharma, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Lyvgen Biopharma, Nextcure, Pfizer, Philogen, Merck Sharpe & Dohme, Corbus Pharmaceuticals, Rakuten Medical, and Genmab

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support